MEDP - Medpace Holdings - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58506Q1094
Clinical Trials, Drug Development, Medical Device Development, Laboratory Services
Medpace Holdings, Inc. is a leading provider of clinical research-based drug and medical device development services, operating across North America, Europe, and Asia. The company's comprehensive suite of services supports the entire clinical development process, from Phase I to Phase IV, across various therapeutic areas.
Medpace offers a range of services tailored to the needs of the pharmaceutical, biotechnology, and medical device industries. These services include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance, new drug application submissions, and post-marketing clinical support. This enables clients to navigate the complex clinical development process efficiently and effectively.
In addition to its core services, Medpace provides specialized support for clinical trials, including bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support. This comprehensive approach enables clients to access a single, trusted partner for all their clinical development needs.
Founded in 1992, Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio, and has established itself as a trusted partner for companies seeking to bring innovative treatments and devices to market. With a strong track record of delivering high-quality services, Medpace is well-positioned to support the evolving needs of the life sciences industry.
Drawdown (Underwater) Chart
MEDP Stock Overview
Market Cap in USD | 9,932m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC SubIndustry | Life Sciences Tools & Services |
TER | 0.00% |
IPO / Inception | 2016-08-11 |
MEDP Stock Ratings
Growth 5y | 86.7 |
Fundamental | 66.2 |
Dividend | |
Rel. Performance vs Sector | 0.89 |
Analysts | 3.64/5 |
Fair Price Momentum | 405.83 USD |
Fair Price DCF | 377.75 USD |
MEDP Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
MEDP Growth Ratios
Growth Correlation 3m | -64.5% |
Growth Correlation 12m | 28.6% |
Growth Correlation 5y | 91.5% |
CAGR 5y | 38.83% |
CAGR/Mean DD 5y | 3.25 |
Sharpe Ratio 12m | 0.78 |
Alpha vs SP500 12m | -18.42 |
Beta vs SP500 5y weekly | 1.38 |
ValueRay RSI | 77.20 |
Volatility GJR Garch 1y | 79.71% |
Price / SMA 50 | 6.21% |
Price / SMA 200 | -3.91% |
Current Volume | 358.1k |
Average Volume 20d | 409.8k |
External Links for MEDP Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of November 10, 2024, the stock is trading at USD 362.79 with a total of 358,083 shares traded.
Over the past week, the price has changed by +13.53%, over one month by +7.28%, over three months by -5.15% and over the past year by +31.75%.
According to ValueRays Forecast Model, MEDP Medpace Holdings will be worth about 455.2 in November 2025. The stock is currently trading at 362.79. This means that the stock has a potential upside of +25.47%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 355.3 | -2.08 |
Analysts Target Price | 269.5 | -25.7 |
ValueRay Target Price | 455.2 | 25.5 |